Deutsche Bank
BBNX

Deutsche Bank’s Beta Bionics BBNX Stock Holding History

Deutsche Bank’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$438K Buy
43,701
+4,401
+11% +$65.1K ﹤0.01% 2643
2025
Q4 		$1.2M Buy
39,300
+1,296
+3% +$34.6K ﹤0.01% 2104
2025
Q3 		$755K Buy
38,004
+24,345
+178% +$428K ﹤0.01% 2330
2025
Q2 		$199K Buy
13,659
+1,580
+13% +$22.4K ﹤0.01% 2968
2025
Q1 		$148K Buy
+12,079
New +$225K ﹤0.01% 3078

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deutsche Bank's BBNX Position: Q1 2026 in Review

Deutsche Bank increased its Beta Bionics (BBNX) stake by 11% in Q1 2026, buying an estimated $65.1K and bringing the position to 43,701 shares worth $438K. The position accounts for ﹤0.01% of the portfolio, ranked #2643.

Deutsche Bank first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.2M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Deutsche Bank held 43,701 shares of Beta Bionics worth $438K as of Q1 2026.
  • Deutsche Bank bought 4,401 Beta Bionics shares in Q1 2026, an estimated $65.1K.
  • Beta Bionics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2643 holding.
  • Deutsche Bank first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Deutsche Bank's Beta Bionics position peaked at $1.2M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.